Adverse events following quadrivalent meningococcal diphtheria toxoid conjugate vaccine (Menactra®) reported to the Vaccine Adverse Event Reporting System (VAERS), 2005-2016. [PDF]
Myers TR +7 more
europepmc +1 more source
Safety and immunogenicity of Vi-diphtheria toxoid typhoid conjugate vaccine among children below 2 years: a systematic review and meta-analysis. [PDF]
Mohamed Taha A +9 more
europepmc +1 more source
Diphtheria Toxin-Antitoxin and Toxoid
W H, Park, M C, Schroder
openaire +3 more sources
FORMALINIZED DIPHTHERIA TOXOID (ANATOXIN)
openaire +3 more sources
Impact of the US Maternal Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis (Tdap) Vaccination Program on Preventing Pertussis in Infants 2 to <6 Months of Age: A Case-Control Evaluation. [PDF]
Skoff TH +9 more
europepmc +1 more source
Antibody persistence to diphtheria toxoid, tetanus toxoid, Bordetella pertussis antigens, and Haemophilus influenzae type b following primary and first booster with pentavalent versus hexavalent vaccines. [PDF]
Wanlapakorn N +5 more
europepmc +1 more source
Comparison of Immune Responses to Two Quadrivalent Meningococcal Conjugate Vaccines (CRM197 and Diphtheria Toxoid) in Healthy Adults. [PDF]
Kim HW, Lee S, Lee JH, Woo SY, Kim KH.
europepmc +1 more source
During the last quarter of 2000, the U.S. Public Health Service learned of a shortage of tetanus and diphtheria toxoids (Td) and tetanus toxoid (TT) resulting from decreased production of these vaccines by the two U.S. manufacturers. Previously published recommendations outlined priorities for use of the limited supply of Td and TT.
openaire +1 more source

